Concepedia

Takashi Sekida

TS

4

Publications

113

Citations

4

H-Index

1991

Active since

Affiliations

Hokkaido University(Current)

Nagoya University

Nagoya Medical Center

National Institute of Biomedical Innovation, Health and Nutrition

VLP Therapeutics (United States)

Takashi Sekida is an author at Hokkaido University specializing in viral immunity, vaccination, and vaccine safety.

ORCID

Top concepts

Publications per year

1991–2024

4

Publications

4

Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study

Wataru Akahata, Takashi Sekida, Takuto Nogimori et al. · Cell Reports Medicine · 2023 · 33 citations · Full text

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern

Mai Komori, Takuto Nogimori, Amber L. Morey et al. · Nature Communications · 2023 · 32 citations · Full text

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine

Masayuki Aboshi, Kenta Matsuda, Daisuke Kawakami et al. · iScience · 2024 · 27 citations · Full text

, , +13

Selective DNA cleavage by elsamicin A and switch function of its amino sugar group

Motonari Uesugi, Takashi Sekida, Shinsuke Matsuki et al. · Biochemistry · 1991 · 21 citations

, , +17

Rows per page

1–4 of 4